Please use this identifier to cite or link to this item:
Title: SEOM clinical guideline in nasopharynx cancer (2017).
Authors: Pastor, M
Lopez Pousa, A
Del Barco, E
Perez Segura, P
Astorga, B Gonzalez
Castelo, B
Bonfill, T
Martinez Trufero, J
Grau, J Jose
Mesia, R
Keywords: Locally-advanced disease;Nasopharynx cancer;Recurrent/metastatic disease;Treatment guidelines
metadata.dc.subject.mesh: Carcinoma
Nasopharyngeal Carcinoma
Nasopharyngeal Neoplasms
Issue Date: 2-Nov-2017
Abstract: Nasopharyngeal carcinoma (NPC) is distinct from other cancers of the head and neck in biology, epidemiology, histology, natural history, and response to treatment. Radiation therapy is an essential component of curative-intent of non-disseminated disease and the association of chemotherapy improves the rates of survival. In the case of metastatic disease stages, treatment requires platinum/gemcitabine-based chemotherapy and patients may achieve a long survival time.
metadata.dc.identifier.doi: 10.1007/s12094-017-1777-0
Appears in Collections:Producción 2020

Files in This Item:
File SizeFormat 
PMC5785612.pdf347,47 kBAdobe PDFView/Open

This item is protected by original copyright

This item is licensed under a Creative Commons License Creative Commons